The Week Ahead: 16-20 December (TSTL, DOTD)
Good afternoon and welcome to the Week Ahead.
We’re in the official run down to the end of the year, with very few company announcements in the schedule. In fact, I would say we’re getting to the time of year when companies scheduling announcements may be doing so in the hope that at this time of year, no one cares. Look out for dividend cuts and minor profit warnings from some low profile companies!
We’re also at the time of year when it is definitely acceptable to watch Trading Places. Which is, in my opinion, the best investing film.
Thank you all for your engagement and suggestions on last week’s article. I’ve started trying to address some of those requests:
GSK analysis - I have taken a closer look at the investment case of the British pharma giant. You can read my verdict here.
Garmin - I have started delving into the investment case and have added the company to my 2025 watchlist. I’ll look to publish my thoughts in detail over Christmas. Incidentally, Garmin is also on my Christmas list.
The week in review
No signs yet of a Santa Rally.
Interest rate cuts in the Europe provided some stimulus to the Stoxx on Wednesday. While the tech-heavy Nasdaq Index hit historic highs on Thursday when it opened trading north of 20,000 for the first time ever.
Both the US and UK interest rate decisions are due next week and current thinking is that while the Federal Reserve is likely to trim rates, the Bank of England will be holding firm. Lower borrowing costs could yet provide some more sparkle to the US, but London’s markets continue to provide slightly less Christmas cheer than their global counterparts.
At Stockopedia we’ve covered the results or news of 32 companies, you can catch up on all of our news analysis via this link.
A couple of company highlights from the week for me:
I have pondered whether I should include Games Workshop (LON:GAW) as a highlight, because it would be the second week in a row, but news of the company’s deal with Amazon this week is a definite win for the week. Roland covered the news on Tuesday.
I recently spent £40 in one order at Domino's Pizza (LON:DOM) and endured a difficult wait while the driver struggled to find my house. But I still love it as a consumer. So I am always interested in company numbers. On Tuesday management reported full-year trading in line, with improved growth in Q4, vs H1 and Q3. Roland covered the stock on Monday.
Further afield there have been some eye-catching business headlines. US chocolate company Hershey Co (NYQ:HSY) saw its share price spike after reports that it might be a takeover target for Cadbury’s owner Mondelez International (NSQ:MDLZ). The deal would need to be signed off by the family trust, which still controls 80% of the voting rights at Hershey via its Class B shares. At the moment, takeover talks are only in the early stages and there has been no official bid. But any firm offer might encourage more bidders to come forward. Nestle, for example, has a chocolate division. And Warren Buffett’s Berkshire Hathaway likes the industry.
There’s also been takeover news in the advertising space. Omnicom (NYQ:OMC) has confirmed a $13.5bn takeover of Interpublic of Companies (NYQ:IPG) to create the world’s largest advertising agency. It’s a deal which wouldn’t have been given the light of day only a few years ago, when takeover rules would have likely deemed the combined companies too much of a monopoly. But the world of advertising has changed and agencies don’t hold the same power in the market as they once did. Today, advertising power lies at the feet of Alphabet and Amazon. The Omnicom/IPG deal is likely to trigger more merger speculation in the industry. WPP’s share price has risen this week.
The car market (which I keep looking for time to analyse properly) continues to drum up headlines. This week, General Motors Co (NYQ:GM) has announced it’s pulling out of the robo-taxi market due to an increasingly competitive landscape. The company previously operated self-driving taxis via its Cruise division, but was forced to pull its vehicles off the roads after a fatal accident involving a pedestrian. Now the company says it will change its focus to personal autonomous vehicles and will likely move investment from Cruise into its own AVs.
The Week Ahead: 16-20 December
Onto next week. First up here is Graham’s economic calendar for the upcoming week.
Economic Calendar
Tuesday 17th | ||
07:00 | United Kingdom | Unemployment Rate |
13:30 | United States | Retail Sales |
Wednesday 18th | ||
07:00 | United Kingdom | Inflation Rate |
19:00 | United States | Fed Interest Rate Decision |
Thursday 19th | ||
12:00 | United Kingdom | BoE Interest Rate Decision |
Friday 20th | ||
07:00 | United Kingdom | Retail Sales |
13:30 | United States | PCE Inflation Rate |
Companies Reporting
The following table is a comprehensive overview of companies reporting this week. I have included some stand-out AGMs as it’s such a quiet week. Some of these are interesting smaller companies, so that’s where the focus of my analysis is this week.
UK | US (all after market close) | |
Monday 16 Dec | Tristel (AGM) Allergy Therapeutics (AGM) | |
Tuesday 17 Dec | Chemring Videndum | |
Wednesday 18 Dec | Integrafin Beeks Financial Cloud (AGM) dotDigital (AGM) | Micron Technologies |
Thursday 19 Dec | Time Finance FIH | FedEx Nike |
Friday 20 Dec |
Monday: Tristel
Tristel (LON:TSTL) is one of the UK’s great small caps.
Prior to its formation in 1993, the gold standard for disinfecting hospital equipment was a compound called glutarealdehyde. It was known to be toxic, but it was the best option. Then Tristel launched its chlorine dioxide formulation, which has become the new gold standard. Most hospitals in the UK are customers and the company has almost 100% domestic market penetration.
But maximising the market leaves very little room for growth, which is why Tristel has spent most of the last decade expanding its international opportunities. In FY2024, the company generated 61% of its revenues from markets outside of the UK. The company’s two product suites (Tristel and Cache) are now sold in 61 countries.
But while Tristel is already the market leader in the Europe, the Middle East and the Asia Pacific regions, it’s the massive North American market which provides both the opportunity and the threat.
Tristel has attempted to make significant in-roads in the US for many years. But, like many small cap British companies, it has become tangled in the complex regulation, manufacturing environment and bureaucracy.
In 2023, the company gained FDA approval for its foam disinfectant for ultrasound probes and started selling the product in the US for the first time in 2024. But in FY24 results, management said that the company’s manufacturing partner had encountered “more purchasing bureaucracy” than originally expected, which has “slightly extended the timeline for some adopters to come on board”.
And this is the story with Tristel. The promise and expectation of US riches is always present, but it often comes tinged with disappointment.
Still, sales growth remains impressive. Over the last five years, revenues have grown at a compound annual rate of 10%. Gross margins are very high, as the company sells mostly via incredibly sticky licences. Operating margins have averaged 15% in the last five years.
Megan’s view:
I like Tristel, it’s a fabulous company which does a lot for showcasing the potential value of companies on Aim.
But it hasn’t been a great investment of late. Sure, investors have received a nice chunk of cash via dividends, but the share price hasn’t really gone anywhere since 2020. Earnings expectations for the year to June 2025 have tapered off and they have been cut for the following year.
Investors are currently of the mindset that earnings growth of 15% next year, falling to 13% the following year isn’t quite enough to justify the price to earnings ratio of 22x based on the company’s current share price of 395p.
But I am more positive than the market. I think there is a lot of untapped potential in the US, which the new chief executive (who took over from the company's retiring founder in September) might be able to crack. I don’t expect this to be a quick turnaround, but I do think this is a good opportunity for the long term. And as the PE ratio is lower than it’s been for a while, I am rating this one GREEN.
Wednesday: dotDigital
After the shine came off dotDigital (LON:DOTD) in the wake of the pandemic, private investors and then institutions sold out en masse. The company’s share price is 68% off its 2021 highs and though there are still signs of good quality, growth has never quite recovered enough to justify a collective leap back in.
dotDigital is an online marketing platform, which sells its solutions to customers in a wide range of industries primarily via licences. Just under 80% of the company’s revenues come from recurring sources, with a further 14% delivered by customer contracts which are ‘predictably repeating’.
It’s a business model that lends itself to very low sales costs. In 2024, the company spent just £14m on the ongoing management of its tech platform, meaning gross margins were over 90%.
The bulk of company costs are in staff and in 2024, the company spent £27m of its total £47m of operating costs on wages and bonuses. Marketing is also a big chunk of expenditure. Aside from the fact that dotDigital has 266 staff in its sales and marketing team (out of a total 451), it spent £5m on direct marketing and partner commission. Rising staff costs have contributed to a fall in operating margins in the last few years, from 26% in 2019 to 15% in 2024.
There is a conspicuous lack of expenditure on the platform and technology in the company’s income statement, but capital expenditures have leapt up in recent years. In 2024, the company spent £9.9m on capex. Amortisation has climbed from £2m in 2018 (the first year it started capitalising its development costs) to £9m last year.
dotDigital remains cash generative. In 2024, free cash flow was £11.2m, equivalent to 84% of net income. The company returned £3bn to shareholders via dividends and paid down £1m of its very small pile of debt. The net cash position at the year end was £39m, despite an £18m investment in a bolt-on acquisition.
Megan’s view
I can’t get as excited about dotDigital as I once could.
For a start, the company seems to be spending a lot but struggling to add new customers. In 2024, revenues rose by £10m, with about £9m of that delivered by higher average spend per customer. That suggests new customer acquisition is only just higher than churn.
I also preferred it when the company expensed its tech development. It is no longer clear exactly where the company is investing in improving its product and whether that is delivering any value.
Sales growth remains impressive (although in 2024, that was bolstered by acquisitions), but weakening margins means profit growth hasn’t kept pace with the top line. Earnings were hit in 2024 by the cost of the acquisition and are expected to rise again in 2025, but forecast growth isn’t as strong as it was back in dotDigital’s heyday.
The market has its positives and negatives. On the one hand, demand for digital marketing expertise is always on the up, but on the other, companies are feeling the squeeze of rising costs elsewhere and marketing budgets tend to be the first culled.
On the surface, this continues to be a high quality operator in an interesting section of the tech market, but underneath there are a lot of problems which leave me uninspired. AMBER/RED
Disclaimer
This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.


19 comments
Megan and Bohenie
Thankyou for responding to my BPR query last week in the Week Ahead article. KBR.
Weekly Wrap
UK indices underperformed on the weekly led by the FTSE250 giving back a lot of the early December gains with small cap AIM showing similar (plot)
Dollar and 10 year yields making the biggest gains in the past week while oil led in the commodities space +4% on the week . Gold manage to eek out a gain despite the DXY but looks to be losing some steam while many of the precious metals respected their denominator and sold-off with silver taking the brunt . Worth noting iron ore turning green and copper holding unch as China's HSI closed the week 0.5% to the good on more stimulus hopes
Not huge evidence of sleigh bells yet : mega caps have been sideways since May in a £7900-£8450 range, the mid cap FTSE250 is also rangebound in what looks like a consolidating bull flag from the Aug '24 highs while AIM is still the weakest link but is showing some signs of basing : if it holds and rallies off the 50MA next week around 734 it may auger some good things into year end and early 2025.
If oil stays bid next week it should help across the mcap range
PMIs tomorrow in Asia, Europe and US may have some directional impacts though Retail Sales across regions, CPI/PCE and BoJ BoE interest rates likely to be of more impact ...
.... it is the week before Christmas so liquidity may well be thin and bumpy and more "seasonal liquidity" may also be in play
in sector terms the stand out winner over the past week and month has been Personal Goods up over 30% on the month and 4% on the week with big recover gains in the likes of Burberry (LON:BRBY) Dr Martens (LON:DOCS) Watches of Switzerland (LON:WOSG) while Warpaint London (LON:W7L) takeout of Brand Architekts (LON:BAR) added to the cheer
on a relative bullish/bearish basis, this sits in the upper right quadrant as names advance in both medium and longer terms treads (see median plot ) along with Consumer Services , Tobacco , Utilities and Banks.
The bottom left quad (declining on both timescales) sits Renewables, Home Builders, Industrial Materials , Oil & Gas, Pharmaceuticals
here's a weekly heatmap for all sectors with bright spots in Banks, Personal Care and Grocery , Tobacco , Insurance Electronic and Electrical, Personal Goods , Medical Equipment
The Week Ahead in Earnings
.. light week with 11 names, 0.5% of the LSE market cap with Bunzl (LON:BNZL) being the only megacap
5 FTSE 250s inc Chemring (LON:CHG) SThree (LON:STEM) Serco (LON:SRP) Integrafin Holdings (LON:IHP) Hollywood Bowl (LON:BOWL)
Names in the below are coloured most bearish (deep red) too most bullish (bright green) on a relative scale based on an aggregate score (price relative to common moving averages )
Interactive version of the below here (not very mobile friendly )
trying to pin down company reporting dates is a black art e.g Tristel has an AGM Monday where it often updates on earnings though it is not a formal earnings date, FY 24 should report mid Jan '25
SThree (LON:STEM) already reported last week and it was not pretty.
thanks - was out of action last week but does look like a car crash result: these visuals are built by machines so based on expected dates- always a case of Trust but Verify
Yes, l think the UK should have, more scheduled updates, like the US markets.
Also l prefer reporting after the market closes rather than 7am.
Thoughts for future car market thematic, which is at the forefront of high tech.
Tesla (NSQ:TSLA) boosted by the tariff 'threat' and flying as high as his space ships. But investors may not have safe arms to collect them when the inevitable happens. But they do say don't bet against Elon Musk.
The Chinese may get whacked to 'level the playing field', for Tesla, but China is a big market for them so Musk needs to tread carefully.
I'm not much interested in the autonomous angle, trying to remedy a problem that isn't there, but has other 'benefits' like war machines. Drones have already changed this space (all made in China of course).
The Chinese will rule autonomy anyway if regulators in the US are less comfortable with 'accidents' and can get more real world testing data. Baidu (NSQ:BIDU) already employs driverless cars, as well as an other businesses such as a successful Chinese search engine. Mobileye Global (NSQ:MBLY) does driver assistance systems. Alphabet (NSQ:GOOGL) are testing Waymo cars in London.
I see the MG branded cars everywhere in London, Chinese SAIC (not sure if can invest, maybe one of the ETF's). KIA is now a mainstream car in the UK and very good too. London Taxi's are now electric by Geeley under LEVO brand, and do a very nice van which looks far nicer than the Tesla truck.
BYD Co (PNK:BYDDY) I think sell more cars than Tesla, have a EV battery division and sells energy storage units. The cars are sold in China but could develop overseas to friendlier markets.
CATL ships 36% of worldwide batteries, far more than Tesla.
Maybe a humanoid robot will be the ultimate solution for driverless taxis. A friendly chatterbox, perhaps with a Micheal Caine accent (changeable of course) who could probably calculate your tax return whilst driving you to see Mum. Can swivel the old 'swede' so better than fixed point sensors. Plus safer for the ladies out late at night.
Total Recall anyone.
And if you buy a drone for christmas well guess where it comes from .......
All of the above arguably sell more cars, batteries, have higher growth and together a lower valuation than that of Tesla. They are on the US market or through an ETF.
China also produces most of the rare earths needed for a lot of tech, but I would guess the the US has these as well just not bothered to exploit them yet.
Blue Bird (NMQ:BLBD) $1bn US school bus co with several low or zero carbon power solutions. Currently below its 200ma so put an alert for when it breaks above.
Could we please have a link to your new podcasts on the main splash screen?
Many thanks.
dotDigital (LON:DOTD) paying £3bn in divis, now that's the type of share I like in my portfolio!
I would love it too if divi was that high. Which it isn’t, decimal place has moved methinks!
Tristel (LON:TSTL) watch out the directors share options.
Also directors have sold a lot of shares this.
Is this company more for the directors benefit or shareholders?
"directors have sold a lot of shares"
This never inspires confidence.. however...
Isn't Swinney the previous CEO/founder who handed over to Sassone? Also, istr on one of Paul Hill's podcasts that one of his interviewees described Dixon the CFO as having a close working relationship with him and that she thought she might be hoping to take over as CEO.
If I'm correct in these "stories" it might excuse those two cashing in to some extent. I see that Sassone was with Massimo in the US so hopefully he went into the job at Tristel (LON:TSTL) with his eyes open to the hurdles in the US..
I believe Swinney and Dixon are married! Other than that yes. Paul Swinney was the LT CEO who has now retired
!
The issue is the directors are getting £ millions of share options and the profits are shown before these are deducted.. Paul Scott has covered this in the past.
Trading Places… The Big Short for me. Otherwise, great read, Megan. Thank you and have a great Christmas.
Tristel (LON:TSTL) Megan, thanks for your views on this company, which appeared on my watchlist late October. Whilst it remains on the list it did not appeal to me looking at progress of the stock price but I remained intrigued with the financials. Now I know the story and will keep an eye on this one. Trading Places is a classic Christmas film in my household. “It was the Dukes, it was the Dukes!’’
Next week's list includes two of my current favourites:
Beeks Financial Cloud (LON:BKS) and Time Finance (LON:TIME).
The BKS entry is for their AGM so unlikely to offer much news. Always the chance however that we may get an inkling of an other exchange ready to sign up...
TIME is the one I am watching closely. The traditional clearing banks have apparently all but vacated new lending to SMEs leaving field open to TIME (and others). Management here have not put a foot wrong so far and the opportunity to grow rapidly is there if the economy makes even half decent growth. I am hoping for some indication that TIME is seeing some 'early spring shoots'.
Comprehensive rundown, many thanks Megan, think the key events will be the interest rate decisions.